Genialis
PrivateLast Round
Series A
Mar 29, 2023
Total Funding Raised
$15.3M
Company Overview
Genialis is a precision oncology company that develops clinically actionable RNA-based biomarkers using artificial intelligence and machine learning to predict patient responses to therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics, Data Integration
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genialis Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Genialis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 29, 2023 | ||||
| Grant | Oct 14, 2021 | ||||
| Seed | Nov 13, 2017 |
Key People
Founding team and executive leadership
Genialis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taiwania Capital | Series A |
| P5 Health Ventures | Series A |
| First Star Ventures | Series A, Seed |
| Redalpine | Series A, Seed |
| Pikas | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 2, 2025
AI-powered biomarkers for pancreatic cancer in collaboration with Cleveland Clinic.
- Oct 2, 2025
Partnering with Cleveland Clinic to develop AI biomarkers for pancreatic cancer.
Genialis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genialis's valuation, stock price, and market status.